Invasive Giant Cell Urothelial Carcinoma

subtype

Identifier: CI-CAN-00002956
Entity page: /cancer/invasive-giant-cell-urothelial-carcinoma ↗
Edges: 15

Neighbours: 12 drugs3 trials
Drawn: 15 of 15 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Invasive Giant Cell Urothelial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived12 of 12
→ investigated in trials for	Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Invasive Giant Cell Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Invasive Giant Cell Urothelial Carcinoma studied in …STUDIED_INderived3 of 3
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 3 trials mapped (2 active)	—	—	Invasive Bladder Giant Cell Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 3 trials mapped (2 active)	—	—	Invasive Bladder Giant Cell Urothelial Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 3 trials mapped (2 active)	—	—	Invasive Bladder Giant Cell Urothelial Carcinoma	1	Observed	clinicaltrials	graph →

Invasive Giant Cell Urothelial Carcinoma studied in …STUDIED_INderived3 of 3

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 3 trials mapped (2 active)

—

Invasive Bladder Giant Cell Urothelial Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT07667335Phase 1/Phase 2 · recruiting

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 3 trials mapped (2 active)

—

Invasive Bladder Giant Cell Urothelial Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03912818Phase 2 · terminated

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 3 trials mapped (2 active)

—

Invasive Bladder Giant Cell Urothelial Carcinoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains